Glycaemic control and pregnancy outcomes with real-time continuous glucose monitoring in gestational diabetes (GRACE): an open-label, multicentre, multinational, randomised controlled trial.

Saved in:
Bibliographic Details
Title: Glycaemic control and pregnancy outcomes with real-time continuous glucose monitoring in gestational diabetes (GRACE): an open-label, multicentre, multinational, randomised controlled trial.
Authors: Linder T; Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria., Dressler-Steinbach I; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Obstetrics, Berlin, Germany., Wegener S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Obstetrics, Berlin, Germany., Schellong K; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Obstetrics, Berlin, Germany., Schmidt S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Obstetrics, Berlin, Germany., Eppel D; Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria., Monod C; Department of Obstetrics and Prenatal Medicine, University Hospital Basel, Basel, Switzerland., Heinzl F; Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria., Redling K; Department of Obstetrics and Prenatal Medicine, University Hospital Basel, Basel, Switzerland., Winzeler B; Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland., Mosimann B; Department of Obstetrics and Prenatal Medicine, University Hospital Basel, Basel, Switzerland., Weschenfelder F; Department of Obstetrics, Jena University Hospital, Jena, Germany., Groten T; Department of Obstetrics, Jena University Hospital, Jena, Germany; Department of Obstetrics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Mittlböck M; Center for Medical Data Science, Institute of Clinical Biometrics, Medical University of Vienna, Vienna, Austria., Jendle J; Faculty of Medical Sciences, Örebro University, Örebro, Sweden., Henrich W; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Obstetrics, Berlin, Germany., Morettini M; Department of Information Engineering, Università Politecnica delle Marche, Ancona, Italy., Bozkurt L; Department of Internal Medicine III and Karl Landsteiner Institute for Metabolic Disorders and Medical University of Vienna, Nephrology, Clinic Hietzing, Vienna Health Care Group, Vienna, Austria., Tura A; CNR Institute of Neuroscience, Padova, Italy., Göbl C; Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria. Electronic address: christian.goebl@meduniwien.ac.at.
Corporate Authors: GRACE study collaborative group
Source: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2026 Jan; Vol. 14 (1), pp. 50-61. Date of Electronic Publication: 2025 Nov 24.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-8595
DOI:10.1016/S2213-8587(25)00288-8